In recent years, Cell, Tissue and Gene Therapy (CTGT) treatments and products have experienced rapid growth both in China and around the globe. According to a report by China's Center for Drug ...
Amerigo Scientific launched a comprehensive portfolio of GMP-grade proteins tailored to accelerate the development and ...
What is the current status of cell therapies today? It's an exciting time to be in cell therapy manufacturing and commercialization, particularly in the oncology space. This year alone, we've seen the ...
USANewsGroup.com News Commentary -- The global cell therapy market is projected to surpass $8.2 billion in 2026, driven by a wave of clinical breakthroughs and manufacturing milestones reshaping ...
First data from phase 1b/2 EPCORE NHL-4: Epcoritamab (Epcor) in Chinese patients (Pts) with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL). This is an ASCO Meeting Abstract from the ...
Gallant and MWI have partnered to give veterinary practices safe and reliable access to off-the-shelf stem cell therapies.
Intent that RoslinCT is to perform technology transfer and commercial manufacture of Omisirge® at RoslinCT’s cell therapy manufacturing facility in Hopkinton, MA. Omisirge® is a commercialized ...
The cell therapy manufacturing market offers significant opportunities driven by technological advancements, increasing clinical trials, and growing regulatory approvals. Key growth catalysts include ...
Newspoint on MSN
Stem cell therapy: Stem cell therapy will treat Parkinson's, Japan has approved this special method for the first time in the world
Parkinson's Disease Research: Parkinson's disease is a chronic neurological disorder that affects body movement. Let us tell you about the latest discoveries in its treatment. What is Parkinson's ...
Cell therapy manufacturing is uniquely vulnerable to contamination, variability, and operational burden because the product - ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results